skip to Main Content


In addition to developing the Rome Criteria for diagnosing Functional GI Disorders (FGIDs), the Rome Foundation appoints working teams that address other complex issues in the field. In choosing team members, the Board has selected senior-level members internationally who are directly involved in and who have published in the topic areas chosen by the Board. The purpose of these working team committees is to develop a summary of the research and literature to date and then offer guidelines or recommendations to help advance future research. The teams would then develop a manuscript to be published in a peer-reviewed journal.

Standing Committees

Active Working Teams

Completed Working Teams

Centrally Acting Pharmacological Agents in FGIDs Working Team

Jan Tack, MD, PhD, Co-Chair , Belgium
Douglas A. Drossman, MD, Co-Chair , USA

Post-infection IBS Working Team

Giovanni Barbara, MD, Co-Chair, Italy
Madhusudan Grover, MD, Co-Chair

The Role of Brain Imaging in FGIDs

Emeran Mayer, M.D. Chair, USA
Qasim Aziz, M.D. Co-chair, UK

Asian-Rome Working Team

Kok Ann Gwee MD, PhD, Chair, Singapore
William E. Whitehead, PhD, Co-Chair, USA

Food & FGIDs Working Team

William D. Chey, MD, Co-Chair, USA
Jan Tack, MD, PhD, Co-Chair , Belgium

Microbiota Working Team

Magnus Simrén, MD, PhD, Chair, Sweden
Giovanni Barbara, MD, Co-Chair, Italy

Multinational Committee

Ami Sperber, MD, MSPH, Chair, Israel

Primary Care Committee

Pali Hungin, MD, United Kingdom

Brain Imaging Working Team

Emeran A. Mayer, MD, Chair
David Geffen School of Medicine at UCLA
Center for Neurovisceral Sciences & Women’s Health

Qasim Aziz, PhD, FRCP (London), Co-Chair
The Wingate Institute

Committee on Outcomes/Endpoints in IBS

Michael Camilleri, MD, Chair
Mayo Medical Center

Rome Severity Committee

Douglas A. Drossman, MD, Chair 
UNC Center for Functional GI & Motility Disorders

Lin Chang, MD, Co-Chair
UCLA CNS: Center for Neurovisceral Sciences & Women’s Health

Rome IV Committees

Rome IV: The Functional Gastrointestinal Disorders: Disorders of Gut-Brain Interaction. Through the work of 6 editors, 117 authors from 23 countries on 18 committees, and our administrative staff, Rome IV provides the culmination of a 5-year process with updates in the criteria with 19 chapters that address the organ-based criteria, basic science, physiology, pharmacology & pharmacokinetics, psychosocial aspects, gender, age, society, culture, and the patient’s perspective, design of treatment trials, and development and validation of the Rome IV diagnostic questionnaire.
Herein is a list of the members whose knowledge, experience, and hard work led to this final product.

Back To Top